Compugen Ltd has a consensus price target of $6.07, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Truist Securities, Stifel, and Truist Securities on March 8, 2024, December 19, 2023, and August 23, 2023. With an average price target of $4.33 between Truist Securities, Stifel, and Truist Securities, there's an implied 70.60% upside for Compugen Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/08/2024 | CGEN | Buy Now | Compugen | $2.54 | 96.85% | Truist Securities | Asthika Goonewardene | $4 → $5 | Maintains | Buy | Get Alert |
12/19/2023 | CGEN | Buy Now | Compugen | $2.54 | 57.48% | Stifel | Stephen Willey | $3 → $4 | Maintains | Buy | Get Alert |
08/23/2023 | CGEN | Buy Now | Compugen | $2.54 | 57.48% | Truist Securities | Asthika Goonewardene | → $4 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | CGEN | Buy Now | Compugen | $2.54 | 411.81% | EF Hutton | Tony Butler | → $13 | Reiterates | Buy → Buy | Get Alert |
06/06/2023 | CGEN | Buy Now | Compugen | $2.54 | 411.81% | EF Hutton | Tony Butler | → $13 | Reiterates | → Buy | Get Alert |
05/26/2023 | CGEN | Buy Now | Compugen | $2.54 | 411.81% | EF Hutton | Tony Butler | → $13 | Reiterates | Buy → Buy | Get Alert |
05/24/2023 | CGEN | Buy Now | Compugen | $2.54 | 411.81% | EF Hutton | Tony Butler | → $13 | Reiterates | Buy → Buy | Get Alert |
05/16/2023 | CGEN | Buy Now | Compugen | $2.54 | 175.59% | Oppenheimer | Mark Breidenbach | $8 → $7 | Maintains | Outperform | Get Alert |
02/28/2023 | CGEN | Buy Now | Compugen | $2.54 | 214.96% | Oppenheimer | Mark Breidenbach | → $8 | Reiterates | → Outperform | Get Alert |
02/08/2023 | CGEN | Buy Now | Compugen | $2.54 | -80.31% | Jefferies | Chris Howerton | → $0.5 | Downgrade | Hold → Underperform | Get Alert |
01/05/2023 | CGEN | Buy Now | Compugen | $2.54 | 411.81% | EF Hutton | Tony Butler | → $13 | Initiates | → Buy | Get Alert |
11/15/2022 | CGEN | Buy Now | Compugen | $2.54 | 214.96% | Oppenheimer | Mark Breidenbach | $12 → $8 | Maintains | Outperform | Get Alert |
08/23/2022 | CGEN | Buy Now | Compugen | $2.54 | 57.48% | Truist Securities | Asthika Goonewardene | $14 → $4 | Maintains | Buy | Get Alert |
08/08/2022 | CGEN | Buy Now | Compugen | $2.54 | 57.48% | JMP Securities | Reni Benjamin | $8 → $4 | Maintains | Market Outperform | Get Alert |
08/08/2022 | CGEN | Buy Now | Compugen | $2.54 | 372.44% | Oppenheimer | Mark Breidenbach | $14 → $12 | Maintains | Outperform | Get Alert |
08/05/2022 | CGEN | Buy Now | Compugen | $2.54 | -21.26% | Jefferies | Chris Howerton | → $2 | Downgrade | Buy → Hold | Get Alert |
02/25/2022 | CGEN | Buy Now | Compugen | $2.54 | 451.18% | Oppenheimer | Mark Breidenbach | $17 → $14 | Maintains | Outperform | Get Alert |
02/25/2022 | CGEN | Buy Now | Compugen | $2.54 | 254.33% | SVB Leerink | Daina Graybosch | $16 → $9 | Maintains | Outperform | Get Alert |
04/06/2021 | CGEN | Buy Now | Compugen | $2.54 | 529.92% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
The latest price target for Compugen (NASDAQ: CGEN) was reported by Truist Securities on March 8, 2024. The analyst firm set a price target for $5.00 expecting CGEN to rise to within 12 months (a possible 96.85% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Compugen (NASDAQ: CGEN) was provided by Truist Securities, and Compugen maintained their buy rating.
There is no last upgrade for Compugen.
The last downgrade for Compugen Ltd happened on February 8, 2023 when Jefferies changed their price target from N/A to $0.5 for Compugen Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Compugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Compugen was filed on March 8, 2024 so you should expect the next rating to be made available sometime around March 8, 2025.
While ratings are subjective and will change, the latest Compugen (CGEN) rating was a maintained with a price target of $4.00 to $5.00. The current price Compugen (CGEN) is trading at is $2.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.